Regeneron Pharmaceuticals Inc (REGN)
1012.82
-1.77
(-0.17%)
USD |
NASDAQ |
Oct 04, 16:00
1012.36
-0.46
(-0.05%)
Pre-Market: 20:00
Regeneron Pharmaceuticals Shareholders Equity (Annual): 25.97B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 25.97B |
December 31, 2022 | 22.66B |
December 31, 2021 | 18.77B |
December 31, 2020 | 11.03B |
December 31, 2019 | 11.09B |
December 31, 2018 | 8.757B |
December 31, 2017 | 6.144B |
December 31, 2016 | 4.449B |
December 31, 2015 | 3.655B |
December 31, 2014 | 2.550B |
December 31, 2013 | 1.952B |
December 31, 2012 | 1.245B |
December 31, 2011 | 485.73M |
December 31, 2010 | 527.82M |
December 31, 2009 | 396.76M |
December 31, 2008 | 421.51M |
December 31, 2007 | 460.27M |
Date | Value |
---|---|
December 31, 2006 | 216.62M |
December 31, 2005 | 114.00M |
December 31, 2004 | 182.54M |
December 31, 2003 | 137.64M |
December 31, 2002 | 145.98M |
December 31, 2001 | 266.36M |
December 31, 2000 | 182.13M |
December 31, 1999 | 109.50M |
December 31, 1998 | 131.20M |
December 31, 1997 | 138.90M |
December 31, 1996 | 106.90M |
December 31, 1995 | 67.90M |
December 31, 1994 | 67.10M |
December 31, 1993 | 98.40M |
December 31, 1992 | 87.20M |
December 31, 1991 | 106.20M |
December 31, 1990 | 12.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
11.03B
Minimum
2020
25.97B
Maximum
2023
17.90B
Average
18.77B
Median
2021
Shareholders Equity (Annual) Benchmarks
Amgen Inc | 6.232B |
Eli Lilly and Co | 10.77B |
Vertex Pharmaceuticals Inc | 17.58B |
Pfizer Inc | 89.01B |
AbbVie Inc | 10.36B |